← Company Index
Pharma & CDMOKOSDAQ 4604702 approvals

IVIM Technology, Inc.

Official website

IVIM Technology provides all-in-one intravital microscopes and CRO imaging-analysis services for live-animal organ and tissue research.

As of 2026-10-11, IVIM Technology, Inc. has 2 Korean MFDS device approvals, 8 PubMed-indexed papers on record (counted by the MAA Company Index from its own matching of public databases).

Price

Change

Market cap

Business overview

Source: DART corporate disclosure

Founded in 2017, IVIM Technology listed on KOSDAQ in 2024 as an intravital microscopy company. It offers an all-in-one intravital microscope lineup including confocal microscopes IVM-C, C2, and C3, confocal two-photon microscopes IVM-CM, CM2, and CM3, and two-photon microscopes IVM-MS, MS2, MS3, M2, and M3, along with the IVM-TMS tissue motion stabilizer that reduces tissue movement during imaging. It also provides organ-specific Imaging Window/Chamber kits for the heart, lung, cranium, abdomen, and mammary gland, and runs a one-stop CRO service covering everything from cell-level imaging in live animal models to drug pharmacokinetics analysis.

Products & technology

  • IVM-C/C2/C31st-3rd generation confocal intravital microscope
  • IVM-CM/CM2/CM31st-3rd generation confocal two-photon intravital microscope
  • IVM-MS/MS2/MS31st-3rd generation two-photon intravital microscope (fixed wavelength)
  • IVM-M2/M32nd-3rd generation two-photon intravital microscope (tunable wavelength)
  • IVM-TMSTissue motion stabilizer imaging accessory
  • CRO serviceCell-level imaging and drug pharmacokinetics analysis service using intravital microscopy in animal models
  • Imaging Window/Chamber Kits (Dorsal Skinfold, Heart, Lung, Cranial, Abdominal, Mammary)Organ/site-specific imaging accessories

Regulatory approvals

data.go.kr

2 Korean MFDS device approvals · 2021–2026

  • MFDSFluorescence imaging system2026-08-10
    Product approval · Class 2제인 26-4730 호
  • MFDSCell/histopathologic image processor2021-05-17
    Product approval · Class 1체외 제신 21-690 호

Key disclosures

KRX KIND via OpenDART

Publications

PubMed · affiliation-matched

Patents

KIPRIS · applicant-matched

AI reads

MAA server logs · IP-verified
34
Times AI engines pulled IVIM Technology, Inc.'s records

Pulled records become part of each AI's index and keep feeding its answers. When an AI cites from that index, nothing reaches our server — so actual citations are uncounted here and exceed this number.

1
Fetched fresh mid-answer

Times an AI needed something not yet in its index and fetched this page fresh while answering. Citations served from the index leave no trace here.

33
Index crawls

Collected as raw material for future answers.

0
Direct AI-tool queries (MCP)

Queries from users who connected this index to their own AI.

5
live 0
Last 7 days
27
live 1
Last 30 days
34
live 1
All time
  • OpenAIChatGPT-Userlive1
  • OpenAIOAI-SearchBot25
  • GoogleGoogleOther3
  • PerplexityPerplexityBot2
  • AnthropicClaudeBot2
  • MicrosoftBingbot1

Measured since Aug 27, 2026 · 5 AI engines · last read Oct 10, 2026

User-agent strings can be forged, so we do not count them at face value. We count only requests matched against vendor-published IP ranges, or confirmed by forward-verified reverse DNS. MCP queries are actual calls to this index's tool endpoint.

Connect this index to your AI tool →

Connect this company index directly to your AI

Connect it to ChatGPT or Claude, and your AI queries the full record — profiles, financials, stock data, regulatory approvals, clinical trials, publications and patents — for IVIM Technology, Inc. and every listed Korean medical, bio and AI company.

How to connect (MCP)
Not yet compiled: business overview · R&D. Send us materials and we will add them

Companies approved for the same productsPharma & CDMO

Ranked by how many MFDS product categories overlap. Not a ranking — a pointer to where to look.

Noul Co., Ltd.1 shared

Founded in 2015 and listed on KOSDAQ in 2022, Noul develops the on-device AI diagnostic platform miLab™ for blood and cancer testing.

Vieworks Co., Ltd.1 shared

Vieworks, founded in 1999 and KOSDAQ-listed in 2009, develops X-ray detectors and industrial camera imaging solutions.

ILDONG HOLDINGS CO.,LTD100

Founded in 1941 and listed on the KOSPI in 1975, Ildong Holdings is the holding company of the Ildong Pharmaceutical Group, overseeing pharmaceutical, aesthetic medical device, and drug development affiliates.

Yuyu Pharma, Inc.100

Founded in 1941 and listed on the KOSPI in 1975, Yuyu Pharma is a pharmaceutical company with a co-promotion agreement with Dong-A ST for Tanamin.

IL DONG PHARMACEUTICAL CO., LTD.100

Founded and listed on the KOSPI in 2016, Il Dong Pharmaceutical manufactures products including the Aronamin vitamin line.

Medy-Tox Inc.99

Founded 2000, KOSDAQ-listed 2009, Medy-Tox develops and exports botulinum toxin biopharmaceuticals including Meditoxin and Innotox.

GC Biopharma Corp.97

KOSPI-listed comprehensive pharmaceutical company specializing in blood products and vaccines, with FDA-approved immunoglobulin ALYGLO.

DAEWON PHARMACEUTICAL CO.,LTD85

KOSPI-listed pharmaceutical company behind Coldwon cold medicine and Jangdaewon probiotics, developing a P-CAB drug pipeline.

SAMSUNG BIOLOGICS CO.,LTD.85

Founded 2011, listed 2016 — Samsung Biologics is a biopharma CDMO with 785,000L capacity across five Songdo plants.

GENOLUTION INC.85

Founded in 2006 and listed on KOSDAQ in 2020, Genolution is a molecular diagnostics and RNAi company producing nucleic acid extraction reagents and devices.

AHN-GOOK PHARMACEUTICAL Co., Ltd.85

Ahn-Gook Pharmaceutical sells the cough/expectorant drug Sinecuran and the eye-health supplement Tobicom.

CORESTEMCHEMON Inc.85

Founded in 2003 and listed on KOSDAQ in 2015, Corestem Chemon develops stem cell therapies and provides nonclinical CRO services, including the ALS treatment Neuronata-R.

Sources and updates

Counts on this page are not company-reported figures. MAA matched records from DART, the Korean MFDS, the US FDA, ClinicalTrials.gov, PubMed and KIPRIS to this company itself, by business registration number or registered name, never by name similarity. They may differ from figures the company publishes.

Company basics
Korea Exchange · DART
Business content
Compiled from disclosure filings
Approvals & clinical trials
Korean MFDS (data.go.kr) · US FDA openFDA — updated weekly
Key disclosures
KRX KIND via OpenDART exchange filings — updated daily
Global clinical trials
ClinicalTrials.gov (US NIH) — sponsor-matched, updated weekly
Financials
DART corporate disclosure filings — annual
Publications
PubMed (US National Library of Medicine) — affiliation-matched, updated daily
Patents
KIPRIS (Korea Institute of Patent Information) — applicant-matched, updated monthly
AI reads
Our server logs, IP-verified every 6 hours
AI visibility
Measured 2026-10-01

This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.

Request a correction or addition